ABT vs SMRT · P/E 25, rev $44.33B vs rev $39.8M
Abbott Laboratories (ABT) versus SmartRent Inc (SMRT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
SmartRent Inc (SMRT) is a software - application company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SMRT revenue for 2026-06-30 was $39.8M. Net income was -$5.6M. Revenue was up 3.0% from 2026-03-31 to 2026-06-30. SMRT currently screens at market cap $208.9M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SMRT currently screens at market cap $208.9M.
Not investment advice. Open the ABT and SMRT stock pages for the full models.
Not investment advice.